Insiders Nyxoah SA

Equities

NYXH

BE0974358906

Market Closed - Euronext Bruxelles Other stock markets 11:37:03 2024-06-28 EDT			5-day change	1st Jan Change
6.5 ^EUR	-1.22%		-20.15%	+52.58%

06-24	Stifel Cuts Price Target on Nyxoah to $19 From $27, Maintains Buy Rating	MT
05-24	HC Wainwright Adjusts Nyxoah SA Price Target to $18 From $22, Maintains Buy Rating	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nyxoah Names New Chief Medical Officer	04-12	MT
Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer	04-11	CI
Nyxoah Appoints Maurits Boon as Chief Medical Officer	04-11	MT
Nyxoah Appoints Francis Kim as Chief Regulatory, Quality Officer	11-28	MT
Nyxoah Appoints Chief Commercial Officer	23-05-11	MT
Nyxoah S.A. Appoints Christoph Eigenmann as Chief Commercial Officer	23-05-10	CI
Nyxoah S.A. Appoints Daniel Wildman as Independent Director to Its Board of Directors	23-01-09	CI
Nyxoah S.A. Announces Resignation of Raymond Cohen as Member of the Board of Directors	22-10-24	CI
Nyxoah S.A. Announces Board Changes	22-05-06	CI
Nyxoah To Appoint New CFO In Early January 2022	21-11-09	MT
Nyxoah SA Appoints Rita Johnson-Mills as an Independent Director to Its Board of Directors	21-08-27	CI
Nyxoah NV Appoints Enrique Vega as Chief Executive Officer, Effective of September 1, 2016	16-07-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer